Vaccination des adultes
Statement on the recommended use of Herpes zoster vaccine
This statement provides recommendations for use of Zostavax in Canadian adults. As new information regarding Zostavax and/or the burden of illness becomes available, the recommendations will be reviewed. Issues including cost-effectiveness, acceptability of vaccine programs, and feasibility will be addressed by other provincial or federal groups.
Vaccine research, development and awareness : front line medicine
A special information supplement from the March 5, 2010 issue of the Globe and Mail that celebrates and promotes Canada’s contributions in the development and distribution of disease-fighting vaccines.
Canadian adult national immunization coverage (Adult NICS) survey 2006
Provides a broad measure of coverage of six vaccinations (influenza, pneumococcal disease, hepatitis A and B, pertussis, varicella, and tetanus) among the adult Canadian population.
Prévention de la coqueluche chez les adolescents et les adultes
Vise à mettre à jour la stratégie antérieure de lutte contre la coqueluche, en ce qui concerne notamment les adolescents et les adultes, de façon à tenir compte des résultats de la Conférence nationale de concertation sur la coqueluche qui a eu lieu en mai 2002.
Prevention of pertussis in adolescents and adults
Updates the previous pertussis control strategy, in particular coverage of adolescents and adults, to reflect results of the National Consensus Conference on Pertussis that took place in May 2002.